Navigation Links
Regulatory Affairs: The Key to Russia, New Life Science Webinar Hosted by Xtalks
Date:3/20/2013

Toronto, Canada (PRWEB) March 20, 2013

The regulatory environment in Russia changes rapidly – new clinical trial regulations and restrictions are introduced almost every quarter.

Our panel of leading Russian industry and government experts will help you navigate successfully through the sea of changes. Don’t miss this unique opportunity to interact with one of the co-authors of new amendments to the Russian Federal Law on Circulation of Drugs.

This webinar will include three insightful presentations:

  •     Dr. Yuri Afonchikov, Synergy’s VP for Regulatory Affairs, will discuss the Russian regulatory system through the eyes of a European expert
  •     Dr. Sergei Glagolev, one of the leading experts of the Federal Service on Surveillance in Healthcare (Roszdravnadzor) will discuss biosimiliars, pharmacovigilance and legal amendments in Russia
  •     Mr. Igor Stefanov, Synergy’s General Manager and a proponent of openness and transparency in the Russian CRO business, will analyze the current state of the clinical trial market in Russia and review the upcoming 2013 trends as well as historical data

For more information about this event or to register, visit: http://xtks.in/xto579-event.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year, thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10548873.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
2. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
3. ADVENTRX Announces Establishment of Regulatory Advisory Board
4. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
5. Healthcare, Regulatory and Reimbursement Landscape - Australia
6. Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK
7. Sanguine Appoints Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to Clinical Advisory Board and Ethics Committee
8. RAPS, Eucomed Partner to Provide Online Training to Regulatory Professionals Throughout Europe
9. Webinar on Clinical, Regulatory and Commercialization Strategies for Rare Diseases
10. Webinar to Discuss Biosimilar Regulatory Guidelines in India and Emerging Markets
11. Global Regulatory Milestones for Invibio Biomaterial Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... , Nov. 30, 2016  The Allen Institute ... Collection: the first publicly available collection of gene ... that target key cellular structures with unprecedented clarity. ... these powerful tools are a crucial first step ... better understand what makes human cells healthy and ...
(Date:11/30/2016)... and BEIJING , Nov. 30, 2016 ... provider of genomic services and solutions with cutting edge ... it has completed a USD $75 Million [515 Million ... Ltd.,s CMB International Capital Management ( Shenzhen ... Co., Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment ...
(Date:11/30/2016)... , Nov. 30, 2016   Merck , a ... has entered into a set of agreements with Evotec ... Merck,s collection of genetic reagents such as CRISPR and ... screening expertise offers an accelerated pathway to explore and ... with the identification of new targets, a process that ...
(Date:11/30/2016)... Research Triangle Park, NC (PRWEB) , ... November ... ... drug development company engaged in the development of a new orally administered treatment ... cognitive testing and neuroimaging results of a Phase 2a clinical trial of T3D-959 ...
Breaking Biology Technology:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):